Multicenter Phese II Study of Optimal-XELOX plus Bevacizumab Therapy with Oxaliplatin Stop-and-Go Strategy and Oral capecitabin plus Bevacizumab Maintenance Therapy in Advanced Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: (1)Initial therapy : XELOX+bevacizumab therapy (2)Maintenance therapy : capecitabine+bevacizumab therapy (3)Reintroduced therapy : XELOX+bevacizumab therapy Primary outcome(s): Progression free survival Study Design: Single arm Non-randomized
创建时间：
2010-04-15
